Navigation Links
Clinical trial shows first evidence that anal cancer is preventable
Date:10/26/2011

A large, international clinical trial led by doctors at the University of California, San Francisco indicates that a vaccine to prevent anal cancer is safe and effective, according to a study reported in the Oct. 27, 2011 issue of New England Journal of Medicine.

Though anal cancer is less common than other forms of the disease in the United States, the number of cases has increased in recent years, and is particularly common among men who have sex with men and HIV-infected individuals.

Anal cancer is caused by infection with human papilloma virus (HPV), the most common sexually-transmitted pathogen in the United States. The virus also causes cervical cancer in women, and the vaccine is already approved and routinely recommended to prevent this condition. The new clinical trial suggests that the same vaccine would also protect men, and likely women, against anal cancer.

In the 1990's, UCSF established the Anal Neoplasia Clinic at the UCSF Helen Diller Family Comprehensive Cancer Center, the world's first clinic devoted to promoting research, awareness, screening and prevention of anal cancer. UCSF professor Joel Palefsky, MD, FRCPC, who founded and directs the clinic, led the clinical trial, and has recently founded a new professional society devoted to the study of the disease.

"Almost six thousand people every year in this country are diagnosed with anal cancer, and more than 700 people die from the disease," said Palefsky. "What this trial showed is that those cancers and deaths could be prevented."

The trial involved a group of 602 men who have sex with men from Australia, Brazil, Canada, Croatia, Germany, Spain and the United States all of whom had at least one, but no more than five, sexual encounters and who were between the ages of 16-26 years. All were randomized into groups that either received a placebo or a three-shot injection of the vaccine Gardasil, which protects against HPV 16 and 18, the m
'/>"/>

Contact: Joel Palefsky
jason.bardi@ucsf.edu
415-502-4608
University of California - San Francisco
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. UCSF-Pfizer partnership yields projects aimed at clinical trials
2. Timing for clinical trials for stem cell therapy in spinal cord injuries is right
3. Penn-developed online informed consent tool could boost number of patients in cancer clinical trials
4. European Journal of Heart Failure publishes new randomized controlled clinical study of RESPeRATE
5. Non-verbal clues guide doctor-patient relationships, clinical judgments, U-M study finds
6. Abiraterone acetate improves fatigue in prostate cancer patients, says international clinical trial
7. TGen-Virginia G. Piper Cancer Center launches clinical trial for drug to treat lung cancer
8. John Theurer Cancer Center among first clinical trial sites to join landmark MMRF study
9. New report on creating clinical public use microdata files
10. Whole-parasite malaria vaccine shows promise in University of Maryland School of Medicine clinical trial
11. Clinical outcomes in PCI patients given sirolimus-eluting and everolimus-eluting stents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Sonoran Vein and Endovascular nurse, Jennifer E. ... Award from The American Association of Nurse ... of nurse practitioners. The Distinguished Preceptorship Award recognizes ... a significant contribution toward increasing the awareness and ... Practitioners (AANP) is the largest full-service national professional ...
(Date:11/26/2014)... 25, 2014 (HealthDay News) -- Vultures have developed highly ... ingest when eating dead animals, researchers report. The ... on the faces and in the guts of 50 ... On average, the faces of the vultures had more ... in their guts, the study found. The findings ...
(Date:11/26/2014)... Exposure to peanut protein in household dust may increase ... skin condition eczema, a new study reveals. About ... are allergic to peanuts. And severe eczema in infants ... the researchers noted. The new study included 359 ... examined the amount of peanut protein the children were ...
(Date:11/26/2014)... 2014 (HealthDay News) -- Parents need to take an ... an expert warns. Parents must make sure sports-playing ... Dr. David Dodick, chair of the American Migraine Foundation ... College of Medicine in Scottsdale, Ariz. in an American ... Any coach involved with teens sports needs to ...
(Date:11/24/2014)... Los Angeles, CA (PRWEB) November 24, 2014 ... to bringing its readers reviews of affordable skin care ... , the casual blog offers readers a wide variety ... the market as well as organic skincare alternatives. , ... Healthy Skin Care Journal’s main content includes thoroughly researched ...
Breaking Medicine News(10 mins):Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Infants With Eczema May Be More Prone to Peanut Allergy: Study 2Health News:Parents Need to Take Lead on Teen Concussion Prevention 2Health News:Skin Care Advice Blog The Healthy Skin Care Journal Now Accessible to the Public 2
... a bacteria resistant to certain antibiotics. This bacteria occurs ... especially in hospitals and nursing homes and is known ... the Netherlands, Sweden, and Norway, where MRSA has been ... facing an increase in incidence with the rates starting ...
... – 'In Zambia, people in the tourist resort city of ... dead chickens at the owners backyards'. // ,Simon ... confirmed evidences were found after thorough investigation of the outbreak'. ... not been cleared yet but residents who cooked and ate ...
... future for those suffering with the deadly disease of Hepatitis C ... that he would speak with the government for the introduction of ... these diseases while administering blood and blood products. ,This ... , These people suffer from the problem of not ...
... Yale university researchers it was found that forced out of work ... rate of heart attacks //. They analyzed about 4,301 people between ... the study were published in the Occupational and Environmental Medicine journal. ... in about 10 years time period as they were forced out ...
... After the vocal demonstrations in hospitals against reservation policy ... face//. This time it is by the staff ... The bone of contention is the incident wherein some ... administration now is taking steps to check overcrowding of ...
... the Wake Forest University School of Medicine and colleagues ... difficult medical procedures //about the dizzy feel of nausea ... strongly affect how they respond to adversity – both ... Ph.D. ‘Being prepared for difficulty can benefit people greatly.’ ...
Cached Medicine News:Health News:Super-bug MRSA Getting Fitter And Out of Control 2Health News:Precautious Measure Help Tolerate Nausea In Patients 2Health News:Precautious Measure Help Tolerate Nausea In Patients 3
(Date:11/26/2014)... Mass. , Nov. 25, 2014 Reinforcing ... Royal Philips (NYSE: PHG AEX: ... and Drug Administration (FDA) for its IQon Spectral ... imaging. This first-of-its kind technology adds a new dimension ... offering the ability to characterize structures based on their ...
(Date:11/26/2014)... , Nov. 25, 2014  Array BioPharma ... announced that its Chief Executive Officer, ... following upcoming conferences.  The public is welcome ... on the Array BioPharma website:  www.arraybiopharma.com ... 2014Time:1:30 p.m.  Eastern Time Location: Palace Hotel, ...
(Date:11/26/2014)... Nov. 25, 2014 Halozyme Therapeutics, Inc. (NASDAQ: ... Healthcare Conference in New York on ... . Dr. Helen Torley , President and Chief ... presentation will be webcast through the "Investors" section of Halozyme,s ... be made available for 90 days following the event. To ...
Breaking Medicine Technology:Philips receives FDA 510(k) clearance for IQon Spectral CT 2Philips receives FDA 510(k) clearance for IQon Spectral CT 3Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2
... Feb. 23, 2012  BioSpecifics Technologies Corp. (NASDAQ: ... in class collagenase-based products marketed as XIAFLEX® in ... today announced that its partner Auxilium Pharmaceuticals, Inc. ... Pharmaceuticals Ltd. (Actelion) for the long-term development, supply ...
... Feb. 23, 2012 Idenix Pharmaceuticals, Inc. (NASDAQ: ... discovery and development of drugs for the treatment of ... the fourth quarter and year ended December 31, 2011 ... virus (HCV) development pipeline. Operational ...
Cached Medicine Technology:BioSpecifics Announces Partnership Between Auxilium and Actelion for XIAFLEX® in Canada, Australia, Brazil and Mexico 2BioSpecifics Announces Partnership Between Auxilium and Actelion for XIAFLEX® in Canada, Australia, Brazil and Mexico 3BioSpecifics Announces Partnership Between Auxilium and Actelion for XIAFLEX® in Canada, Australia, Brazil and Mexico 4Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update 2Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update 3Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update 4Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update 5Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update 6Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update 7Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update 8
...
Medtronic neurosurgery external drainage and monitoring (EDM) products meet a variety of needs for CSF drainage and monitoring....
Lumbar External Drainage System (LED) with Touhy needle is indicated for temporary access to the Lumbar Subarachnoid region as a means of draining cerebral spinal fluid (CSF) in order to reduce incre...
Monitorr ICP external CSF drainage system with self-contained ICP setting....
Medicine Products: